VEGF-B and PDGF modulation of stem cells

Details for Australian Patent Application No. 2004209668 (hide)

Owner Ludwig Institute for Cancer Research Flanders Interuniversity Institute for Biotechnology Licentia, Ltd.

Inventors Eriksson, Ulf; Li, Xuri; Rajantie, Iiro; Salven, Petri; Yla-Herttuala, Seppo; Collen, Desire; Carmeliet, Peter; Alitalo, Kari

Agent Freehills

Pub. Number AU-A-2004209668

PCT Pub. Number WO2004/070018

Priority 60/445,021 04.02.03 US; 60/471,412 16.05.03 US

Filing date 4 February 2004

Wipo publication date 19 August 2004

International Classifications

A61K 038/18 Medicinal preparations containing peptides - Growth factors

Event Publications

8 September 2005 PCT application entered the National Phase

  PCT publication WO2004/070018 Priority application(s): WO2004/070018

13 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209675-An assembly

2004209665-Audio interface device for public address systems